Silence kills the democracy – marking the World Press Freedom Day - 3 May
News 3 May 2021 Augmenter la taille du texte Imprimer la page Imprimer en PDF
A free, diverse and responsible press is a core element of any functioning democracy. 3 May, the World Press Freedom Day acts as a reminder to governments of the need to respect their commitment to freedom of the press and the media - “Freedom of expression, media independence and open deliberation, rather than information control, are the core principles underlying European democracy which will allow us to surmount the great challenges facing our countries.”
It is a day of reflection among journalists and other media actors about their challenges to guarantee press freedom but also to ensure professional and ethical journalism. Equally important, World Press Freedom Day is a day to show our support for those media which are targets of the restraint, or elimination,
Workshop on AU Theme for 2021 calls for enhanced support from African MPs
au.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from au.int Daily Mail and Mail on Sunday newspapers.
Feeding America Publishes Nutrition in Food Banking Toolkit
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Feeding America Publishes Nutrition in Food Banking Toolkit
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Dogs have been called man s best friend because of their loyalty and protection, but now, thanks to Johns Hopkins Medicine researchers and an international team of collaborators, canines may provide an even greater service for their human male companions: prostate cancer screening.
Prostate cancer is the second leading cause of cancer death in men in the developed world. Clinicians have been seeking accurate and reliable noninvasive diagnostic tools to differentiate early stage, less dangerous and more treatable stages of the disease from the aggressive, high-grade and likely-to-spread forms. Standard blood tests for early detection, such as the prostate specific antigen (PSA) test, often miss cancers in men whose PSA levels are within normal levels or overdiagnose men with clinically insignificant tumors or no cancer at all.